RACE have Phase I and Phase II data for AML (previously approved in France for AML)
RACE have last Phase II trial in 2020 for AML
RACE have Phase I, Phase II, Phase III data for Breast Cancer
RACE have strong (albeit early) 2020 preclinical data for Breast Cancer
RACE have Phase II data for Ovarian Cancer
RACE have strong (albeit early) 2021 preclinical data for Ovarian Cancer
RACE are doing further preclinical study for FTO indications for Breast Cancer and Ovarian Cancer
RACE are undoubtedly undertaking preclinical study for Melanoma (FTO) and ccRCC (FTO)
RAC - Charts & Price Action, page-4011
-
- There are more pages in this discussion • 18,723 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.59 |
Change
0.055(3.59%) |
Mkt cap ! $270.1M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.60 | $1.53 | $79.91K | 51.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 23239 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |